Certified by Founder Lodge
Takeda Ventures, Inc.
United States - San Diego, CA
INVESTOR
1 Disclosed Funding Rounds $85,000,000
6 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC
| Company | Date | Round | Raised |
|---|---|---|---|
 Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
 Koneksa |
February, 08 ,2022 | Series C | $45,000,000 |
 OncoResponse |
May, 19 ,2023 | Unknown | $14,000,000 |
 Larkspur Biosciences |
May, 24 ,2023 | Unknown | $35,500,000 |
 Harness Therapeutics |
December, 01 ,2023 | Unknown | $5,067,000 |
 Be Biopharma |
October, 23 ,2024 | Unknown | $82,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
